CDEK
← All drugs Report issue

bgm0504

Peptideexperimental

Clinical trial activity

12 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
7
Phase 3
4
Phase 4
0

Earliest trial started Aug 30, 2023 (NCT06974825)

Timeline

2020s

  1. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2024

    Earliest Phase 1 Sponsor(trial)

  3. Jan 1, 2024

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07239973Phase 1Oct 21, 2025Government of China
NCT07166081Phase 1Aug 11, 2025Government of China
NCT07064486Phase 3Jul 4, 2025Government of China
NCT06929156Phase 1May 8, 2025Government of China
NCT06911203Phase 2Apr 3, 2025Government of China
NCT06920056Phase 1Mar 24, 2025Government of China
NCT06716216Phase 3Dec 1, 2024Government of China, WuXi
NCT06716203Phase 3Dec 1, 2024Government of China, WuXi
NCT06704581Phase 3Oct 28, 2024WuXi
NCT06714955Phase 1Oct 21, 2024Government of China
NCT06973681Phase 2Oct 13, 2023Government of China
NCT06974825Phase 2Aug 30, 2023Government of China
Showing 12 of 12 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of ChinaGovernment111132023
WuXiFor profit3112024
2 organizations
Page 1 / 1